Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules

Atherosclerosis-predominant vasculopathy is a common complication of diabetes with high morbidity and high mortality, which is ruining the patient's daily life. As is known to all, traditional Chinese medicine (TCM) SHENQI compound and western medicine rosiglitazone play an important role in th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Gao, Hong, Duan, Yuhong, Fu, Xiaoxu, Xie, Hongyan, Liu, Ya, Yuan, Haipo, Zhou, Mingyang, Xie, Chunguang
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283585/
https://ncbi.nlm.nih.gov/pubmed/30521536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0207683
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados